# Panalgo

> Panalgo's healthcare analytics platform allows you to focus on what matters most, turning data into insights\.

Generated by Yoast SEO v27.4, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Ella](https://panalgo.com/ella/)
- [Home](https://panalgo.com/)
- [Meghana Shamsunder](https://panalgo.com/rwd-experts/meghana-shamsunder/)
- [Meet Our Real\-World Data Experts](https://panalgo.com/rwd-experts/)
- [IHD Analytics](https://panalgo.com/ihd-analytics/)

## Posts
- [Faster Evidence, Fewer Bottlenecks: How IHD Is Redefining What's Possible in Evidence Generation](https://panalgo.com/blog/faster-evidence-fewer-bottlenecks/): As the demands on real\-world data teams continue to grow, with more data sources, more stakeholders, and more pressure to deliver trusted evidence faster, the tools supporting that work need to evolve just as quickly\.
- [Accelerating HEOR and Real\-World Evidence: How IHD Helps Researchers Turn Evidence Into Impact](https://panalgo.com/blog/accelerating-heor-and-real-world-evidence-how-ihd-helps-researchers-turn-evidence-into-impact/): Health economics and outcomes research \(HEOR\), epidemiology, and real\-world evidence \(RWE\) teams are under growing pressure to deliver meaningful insights faster than ever before\. As healthcare stakeholders demand stronger evidence of clinical, economic, and humanistic value across the product life cycle, researchers need more than data—they need the right combination of technology, expertise, and fit\-for\-purpose evidence sources to turn research into impact\.
- [How Pharma Leaders Are Rethinking Evidence Generation in the AI Era](https://panalgo.com/blog/how-pharma-leaders-are-rethinking-evidence-generation-in-the-ai-era/): Learn what organizations must do to balance speed, transparency, governance, and innovation in an increasingly data\-driven and AI\-reliant environment\.
- [Where Treatment Slows in Metastatic NSCLC: A Real\-World Data Analysis of Care Delays and Access Barriers](https://panalgo.com/blog/where-treatment-slows-in-metastatic-nsclc-a-real-world-data-analysis-of-care-delays-and-access-barriers/): As regulators around the world grow more comfortable with real\-world data \(RWD\) and AI\-enabled evidence generation, pharma companies are rethinking how, and when, they build evidence\. 
- [Using Real\-World Data to Understand the Impact of IRA Policy on Patient Outcomes and Health Equity](https://panalgo.com/articles/using-real-world-data-to-understand-the-impact-of-ira-policy-on-patient-outcomes-and-health-equity/)

## Tags
- [Panalgo News](https://panalgo.com/tag/panalgo-news/)
- [Real\-World Evidence](https://panalgo.com/tag/real-world-evidence/)
- [RWD Analytics](https://panalgo.com/tag/rwd-analytics/)
- [Real\-World Data](https://panalgo.com/tag/real-world-data/)
- [Advanced Analytics and Machine Learning](https://panalgo.com/tag/advanced-analytics-and-machine-learning/)

## Optional
- [Sitemap index](https://panalgo.com/sitemap_index.xml)